NanoRepro AG (NN6)
XETR
Real-time Data
07:00 AM
Day's Range
1.9152 wk Range
1.31Overview - NN6 - NanoRepro AG
Key Statistics
Valuation
Enterprise Value
16.32M
P/E (Trailing)
‪7.39‬
P/E (Forward)
‪47.75‬
PEG Ratio
‪47.75‬
Price / Sales (TTM)
‪5.55‬
Price / Book
‪0.66‬
EV / EBITDA
‪-7.97‬
Profitability
Profit Margin
‪-45.83%‬
Operating Margin
‪-60.04%‬
Return on Assets
‪-3.42%‬
Return on Equity
‪-5.34%‬
Ownership
Shares Outstanding
12.61M
Held by Insiders
‪2.00%‬
Held by Institutions
‪8.94%‬
Price stats
Beta
‪0.46‬
50-Day Avg
‪2.04‬
200-Day Avg
‪1.67‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
2 analysts
Average price target
‪€ 4.45‬Market Cap - NN6 - NanoRepro AG
Peers - NN6 - NanoRepro AG
Peer Comparison
Compared with companies in Diagnostics & Research listed on XETR.
Profile Summary - NN6 - NanoRepro AG
About
NanoRepro AG is a biotechnology company that specializes in the development, manufacturing, and distribution of rapid diagnostic tests. These tests are primarily used in personal and home care health sectors. NanoRepro's portfolio includes products that target infectious diseases, fertility monitoring, and preventive…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
